Abbott Laboratories (ABT)
$103.54
0.18 (0.17%)
ABT Stock Quote Delayed 30 Minutes
Big Pharma Might Already Have Sights on Abbott Spinoff
Abbott's Humira is a dollar-printing temptation for several companies, but Pfizer's tofacitinib could change the rheumatoid arthritis drug landscape.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
181.29B
PE Ratio
32.26
EPS
3.21
Volume (Avg. Vol.)
1.22M
Day's Range
$103.37 - $104.33
52-Week Range
$89.67 - $121.64
Dividend & Yield
$2.04 (1.97%)
ABT Stock Predictions, Articles, and Abbott Laboratories News
3 Large-Cap Stocks Set to Break Out and Score
Investors take notice: These three large-cap stocks are firing on all cylinders -- or are very close to doing so.
Mead Johnson Might Be One to Shed
Sales for Mead Johnson Nutrition's baby food have been robust, but dividends and earnings growth have been mediocre.
Deep-Pocket Drug Companies Poised to Reap Biosimilar Rewards
Only a few companies have the massive resources needed to get going in the upcoming "biosimilars" boom. Who will lead the charge?
ObamaCare Court Test a Non-event for Health Stocks
Health insurance, pharmaceutical companies' gains show confidence that ObamaCare is all but a done deal.
Mead Johnson’s Margins Are Making Abbott Jealous
The profit war is on between the top baby forumula makers.
Abbott Milking More Profits By Imitating Baby Formula Business
Baby formula maker Mead's rising success has competitor Abbott Laboratories trying desperately to catch some of the momentum, which is showing no signs of slowing down.
5 Healthcare Mutual Funds to Buy Now
Healthcare is a recession-proof industry, and health care stocks are great investments for 401k investors. Get your share with these 5 healthcare funds to buy now.
Abbott Labs May Lead a Big Pharma Bounceback
When the sector revives, this stock could break out.
7 Health Care Stocks to Sell
Big pharma is in big trouble, with looming patent expirations and drug generic competition weighing on drug related stocks.
Abbott Labs (ABT) a Top Dividend Stock
Abbott Laboratories (NYSE: ABT) is a top dividend stock that focuses on pharmaceutical drugs and health care products.
